Effective Implementation of MAT to Address Adolescent Opioid Use Disorder
Tuesday, April 24, 2018 · 3:00-4:00 p.m. ET (2:00 p.m. CT)
Description – This webinar will showcase the long-standing Nationwide Children’s Hospital Medication Assisted Treatment for Addiction outpatient program for adolescents and young adults who are addicted to prescription opiates or heroin. It will also highlight federal and other resources to implement an MAT program for adolescent and young adult patients.
Intended Audience – Healthcare professionals who work with opioid treatment programs (OTPs), medication-assisted treatment (MAT), or who serve adolescent patients in any capacity. However, a multi-disciplinary audience of those working in substance use, public health, child welfare/foster care are invited to attend.
Presented by Steve Matson, MD, Division of Adolescent Medicine, Nationwide Children’s Hospital and The Ohio State University, College of Medicine
REGISTER and learn more here: https://register.gotowebinar.com/register/6155278687623025922
Questions? Contact Lesley.Craig@hhs.gov
“Medicated-Assisted Treatment (MAT) is the use of FDA- approved medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders. These medications relieve the withdrawal symptoms and psychological cravings that cause chemical imbalances in the body. MAT programs provide a safe and controlled level of medication to overcome the use of an abused opioid. And research has shown that when provided at the proper dose, medications used in MAT have no adverse effects on a person’s intelligence, mental capability, physical functioning, or employability.” Learn more: www.samhsa.gov/medication-assisted-treatment
Brought to you by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health’s Region 5 Adolescent Health Network, and HHS Substance Abuse and Mental Health Services Administration – Region 5